{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:05:48Z","timestamp":1788627948465,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Activation of the kallikrein-kinin system promotes vascular leakage, inflammation, and neurodegeneration in ischemic stroke. Inhibition of plasma kallikrein (PK) \u2013 a key component of the KKS \u2013 in the acute phase of ischemic stroke has been reported to reduce thrombosis, inflammation, and damage to the blood-brain barrier. However, the role of PK during the recovery phase after cerebral ischemia is unknown. To this end, we evaluated the effect of subacute PK inhibition starting from day 3 on the recovery process after transient middle artery occlusion (tMCAO). Our study demonstrated a protective effect of PK inhibition by reducing infarct volume and improving functional outcome at day 7 after tMCAO. In addition, we observed reduced thrombus formation in cerebral microvessels, fewer infiltrated immune cells, and an improvement in blood-brain barrier integrity. This protective effect was facilitated by promoting tight junction reintegration, reducing detrimental matrix metalloproteinases, and upregulating regenerative angiogenic markers. Our findings suggest that PK inhibition in the subacute phase might be a promising approach to accelerate the post-stroke recovery process.<\/jats:p>","DOI":"10.1186\/s12974-024-03149-w","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:05:02Z","timestamp":1718291102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delayed plasma kallikrein inhibition fosters post-stroke recovery by reducing thrombo-inflammation"],"prefix":"10.1186","volume":"21","author":[{"given":"Steffen","family":"Haupeltshofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Mencl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D.","family":"Szepanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Abberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Blusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Langhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"3149_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"3149_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCULATIONAHA.116.023336","volume":"135","author":"J-T Kim","year":"2017","unstructured":"Kim J-T, Fonarow GC, Smith EE, Reeves MJ, Navalkele DD, Grotta JC, et al. Treatment with tissue plasminogen activator in the Golden Hour and the shape of the 4.5-Hour time-benefit curve in the National United States get with the guidelines-Stroke Population. Circulation. 2017;135:128\u201339.","journal-title":"Circulation"},{"key":"3149_CR3","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1212\/WNL.0000000000012801","volume":"97","author":"AP Jadhav","year":"2021","unstructured":"Jadhav AP, Desai SM, Jovin TG. Indications for mechanical thrombectomy for Acute ischemic stroke: current guidelines and Beyond. Neurology. 2021;97:S126\u201336.","journal-title":"Neurology"},{"key":"3149_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/STROKEAHA.122.038733","volume":"53","author":"SF De Meyer","year":"2022","unstructured":"De Meyer SF, Langhauser F, Haupeltshofer S, Kleinschnitz C, Casas AI. Thromboinflammation in Brain Ischemia: recent updates and future perspectives. Stroke. 2022;53:1487\u201399.","journal-title":"Stroke"},{"key":"3149_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pneurobio.2012.11.004","volume":"101\u2013102","author":"C Albert-Wei\u00dfenberger","year":"2013","unstructured":"Albert-Wei\u00dfenberger C, Sir\u00e9n A-L, Kleinschnitz C. Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system. Prog Neurobiol. 2013;101\u2013102:65\u201382.","journal-title":"Prog Neurobiol"},{"key":"3149_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1084\/jem.20052458","volume":"203","author":"C Kleinschnitz","year":"2006","unstructured":"Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer H-U, Burfeind P, et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med. 2006;203:513\u20138.","journal-title":"J Exp Med"},{"key":"3149_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","volume":"121","author":"I Hagedorn","year":"2010","unstructured":"Hagedorn I, Schmidbauer S, Pleines I, Kleinschnitz C, Kronthaler U, Stoll G, et al. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation. 2010;121:1510\u20137.","journal-title":"Circulation"},{"key":"3149_CR8","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","volume":"120","author":"F Langhauser","year":"2012","unstructured":"Langhauser F, G\u00f6b E, Kraft P, Geis C, Schmitt J, Brede M, et al. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood. 2012;120:4082\u201392.","journal-title":"Blood"},{"key":"3149_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/ana.24380","volume":"77","author":"E G\u00f6b","year":"2015","unstructured":"G\u00f6b E, Reymann S, Langhauser F, Schuhmann MK, Kraft P, Thielmann I, et al. Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation. Ann Neurol. 2015;77:784\u2013803.","journal-title":"Ann Neurol"},{"key":"3149_CR10","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1177\/0271678X17709185","volume":"37","author":"N Percie du Sert","year":"2017","unstructured":"Percie du Sert N, Alfieri A, Allan SM, Carswell HV, Deuchar GA, Farr TD, et al. The IMPROVE guidelines (Ischaemia models: procedural refinements of in vivo experiments). J Cereb Blood Flow Metab. 2017;37:3488\u2013517.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3149_CR11","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"3149_CR12","doi-asserted-by":"publisher","unstructured":"Llovera G, Simats A, Liesz A. Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery. J Vis Exp [Internet]. 2021; https:\/\/doi.org\/10.3791\/62573.","DOI":"10.3791\/62573"},{"key":"3149_CR13","doi-asserted-by":"publisher","first-page":"299ra121","DOI":"10.1126\/scitranslmed.aaa9853","volume":"7","author":"G Llovera","year":"2015","unstructured":"Llovera G, Hofmann K, Roth S, Salas-P\u00e9rdomo A, Ferrer-Ferrer M, Perego C, et al. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Sci Transl Med. 2015;7:299ra121.","journal-title":"Sci Transl Med"},{"key":"3149_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.expneurol.2006.09.006","volume":"203","author":"V Bou\u00ebt","year":"2007","unstructured":"Bou\u00ebt V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol. 2007;203:555\u201367.","journal-title":"Exp Neurol"},{"key":"3149_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2014.00338","volume":"8","author":"TR Doeppner","year":"2014","unstructured":"Doeppner TR, Kaltwasser B, B\u00e4hr M, Hermann DM. Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci. 2014;8:338.","journal-title":"Front Cell Neurosci"},{"key":"3149_CR16","doi-asserted-by":"publisher","first-page":"100493","DOI":"10.1016\/j.bbih.2022.100493","volume":"24","author":"RD Steubing","year":"2022","unstructured":"Steubing RD, Szepanowski F, David C, Mohamud Yusuf A, Mencl S, Mausberg A-K, et al. Platelet depletion does not alter long-term functional outcome after cerebral ischaemia in mice. Brain Behav Immun Health. 2022;24:100493.","journal-title":"Brain Behav Immun Health"},{"key":"3149_CR17","doi-asserted-by":"publisher","first-page":"25860","DOI":"10.1073\/pnas.1905955116","volume":"116","author":"S Haupeltshofer","year":"2019","unstructured":"Haupeltshofer S, Leichsenring T, Berg S, Pedreiturria X, Joachim SC, Tischoff I, et al. Smad7 in intestinal CD4 T cells determines autoimmunity in a spontaneous model of multiple sclerosis. Proc Natl Acad Sci U S A. 2019;116:25860\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3149_CR18","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1084\/jem.138.6.1564","volume":"138","author":"CG Cochrane","year":"1973","unstructured":"Cochrane CG, Revak SD, Wuepper KD. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med. 1973;138:1564\u201383.","journal-title":"J Exp Med"},{"key":"3149_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2008.02.012","volume":"153","author":"D Strbian","year":"2008","unstructured":"Strbian D, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, et al. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience. 2008;153:175\u201381.","journal-title":"Neuroscience"},{"key":"3149_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","volume":"28","author":"R Prakash","year":"2015","unstructured":"Prakash R, Carmichael ST. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. Curr Opin Neurol. 2015;28:556\u201364.","journal-title":"Curr Opin Neurol"},{"key":"3149_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12016-021-08851-8","volume":"60","author":"ML Debreczeni","year":"2021","unstructured":"Debreczeni ML, N\u00e9meth Z, Kajd\u00e1csi E, Farkas H, Cervenak L. Molecular dambusters: what is behind hyperpermeability in bradykinin-mediated Angioedema? Clin Rev Allergy Immunol. 2021;60:318\u201347.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3149_CR22","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1021\/acs.jproteome.1c00259","volume":"20","author":"R-F Gu","year":"2021","unstructured":"Gu R-F, Fang T, Nelson A, Gyoneva S, Gao B, Hedde J, et al. Proteomic characterization of the dynamics of ischemic stroke in mice. J Proteome Res. 2021;20:3689\u2013700.","journal-title":"J Proteome Res"},{"key":"3149_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/STROKEAHA.108.526673","volume":"40","author":"M Austinat","year":"2009","unstructured":"Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, et al. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke. 2009;40:285\u201393.","journal-title":"Stroke"},{"key":"3149_CR24","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/jcbfm.2010.28","volume":"30","author":"F Raslan","year":"2010","unstructured":"Raslan F, Schwarz T, Meuth SG, Austinat M, Bader M, Renn\u00e9 T, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30:1477\u201386.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3149_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/s-0040-1710013","volume":"120","author":"M Visser","year":"2020","unstructured":"Visser M, Heitmeier S, Ten Cate H, Spronk HMH. Role of factor XIa and plasma kallikrein in arterial and venous thrombosis. Thromb Haemost. 2020;120:883\u2013993.","journal-title":"Thromb Haemost"},{"key":"3149_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152509789105444","volume":"7","author":"JW Bryant","year":"2009","unstructured":"Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem. 2009;7:234\u201350.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"3149_CR27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1111\/j.1538-7836.2007.02770.x","volume":"5","author":"AH Schmaier","year":"2007","unstructured":"Schmaier AH, McCrae KR. The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost. 2007;5:2323\u20139.","journal-title":"J Thromb Haemost"},{"key":"3149_CR28","doi-asserted-by":"publisher","first-page":"22887","DOI":"10.1038\/s41598-021-02360-6","volume":"11","author":"V G\u00f6b","year":"2021","unstructured":"G\u00f6b V, Voll MG, Zimmermann L, Hemmen K, Stoll G, Nieswandt B, et al. Infarct growth precedes cerebral thrombosis following experimental stroke in mice. Sci Rep. 2021;11:22887.","journal-title":"Sci Rep"},{"key":"3149_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.expneurol.2014.07.004","volume":"261","author":"YH Tang","year":"2014","unstructured":"Tang YH, Vital S, Russell J, Seifert H, Senchenkova E, Granger DN. Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy. Exp Neurol. 2014;261:417\u201323.","journal-title":"Exp Neurol"},{"key":"3149_CR30","doi-asserted-by":"publisher","first-page":"594672","DOI":"10.3389\/fneur.2020.594672","volume":"11","author":"S Bernardo-Castro","year":"2020","unstructured":"Bernardo-Castro S, Sousa JA, Br\u00e1s A, Cec\u00edlia C, Rodrigues B, Almendra L, et al. Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on Hemorrhagic Transformation and Recovery. Front Neurol. 2020;11:594672.","journal-title":"Front Neurol"},{"key":"3149_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1086\/677356","volume":"4","author":"S Sukriti","year":"2014","unstructured":"Sukriti S, Tauseef M, Yazbeck P, Mehta D. Mechanisms regulating endothelial permeability. Pulm Circ. 2014;4:535\u201351.","journal-title":"Pulm Circ"},{"key":"3149_CR32","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/foc.2007.22.5.5","volume":"22","author":"GA Rosenberg","year":"2007","unstructured":"Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus. 2007;22:E4.","journal-title":"Neurosurg Focus"},{"key":"3149_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/00004647-199811000-00001","volume":"18","author":"S Mun-Bryce","year":"1998","unstructured":"Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998;18:1163\u201372.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3149_CR34","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724\u201332.","journal-title":"J Neurosci"},{"key":"3149_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00004647-200204000-00002","volume":"22","author":"ZG Zhang","year":"2002","unstructured":"Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002;22:379\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3149_CR36","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0002-9440(10)64964-4","volume":"156","author":"HJ Marti","year":"2000","unstructured":"Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156:965\u201376.","journal-title":"Am J Pathol"},{"key":"3149_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.intimp.2007.08.001","volume":"8","author":"U Schulze-Topphoff","year":"2008","unstructured":"Schulze-Topphoff U, Prat A, Bader M, Zipp F, Aktas O. Roles of the kallikrein\/kinin system in the adaptive immune system. Int Immunopharmacol. 2008;8:155\u201360.","journal-title":"Int Immunopharmacol"},{"key":"3149_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fimmu.2018.00156","volume":"9","author":"A Seliga","year":"2018","unstructured":"Seliga A, Lee MH, Fernandes NC, Zuluaga-Ramirez V, Didukh M, Persidsky Y, et al. Kallikrein-Kinin System suppresses type I Interferon responses: a novel pathway of Interferon Regulation. Front Immunol. 2018;9:156.","journal-title":"Front Immunol"},{"key":"3149_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.1810020116","volume":"116","author":"K G\u00f6bel","year":"2019","unstructured":"G\u00f6bel K, Asaridou C-M, Merker M, Eichler S, Herrmann AM, Geu\u00df E, et al. Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release. Proc Natl Acad Sci U S A. 2019;116:271\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3149_CR40","doi-asserted-by":"publisher","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X, et al. Interleukins and ischemic stroke. Front Immunol. 2022;13:828447.","journal-title":"Front Immunol"},{"key":"3149_CR41","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1161\/STROKEAHA.115.007433","volume":"46","author":"SC Cramer","year":"2015","unstructured":"Cramer SC. Drugs to Enhance Motor Recovery after Stroke. Stroke. 2015;46:2998\u20133005.","journal-title":"Stroke"},{"key":"3149_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/ped.2014.0425","volume":"27","author":"S Caccia","year":"2014","unstructured":"Caccia S, Suffritti C, Cicardi M. Pathophysiology of Hereditary Angioedema. Pediatr Allergy Immunol Pulmonol. 2014;27:159\u201363.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"3149_CR43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.106.105064","volume":"318","author":"C Storini","year":"2006","unstructured":"Storini C, Bergamaschini L, Gesuete R, Rossi E, Maiocchi D, De Simoni MG. Selective inhibition of plasma kallikrein protects brain from reperfusion injury. J Pharmacol Exp Ther. 2006;318:849\u201354.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03149-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:32:01Z","timestamp":1721399521000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03149-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03149-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional government authorities (Landesamt f\u00fcr Natur, Umwelt und Verbraucherschutz NRW, LANUV) and guided by the German Welfare Act (German Ministry of Agriculture, Health, and Economic Cooperation).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have seen and agree with the contents of the submitted manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}